Table 1. Clinical backgrounds of HCC patients at the resection stage (n=177).
| Variables | Group A(n=51) | Group B(n=43) | Group C(n=83) | P-value |
|---|---|---|---|---|
| Age (years) | 51.8±13.1 | 54.4±11.7 | 46.4±11.7 | 0.020 |
| Gender, male | 40(78.4%) | 40(93.0%) | 72(86.7%) | 0.123 |
| TBIL, umol/L | 17.5±16.0 | 14.2±5.7 | 14.9±6.1 | 0.226 |
| ALB, g/L | 41.2±4.4 | 41.4±4.5 | 41.6±4.4 | 0.869 |
| PT, s | 12.2±1.7 | 11.7±1.2 | 15.6±26.8 | 0.437 |
| WBC,×109/L | 5.2±2.1 | 5.4±1.4 | 5.6±1.9 | 0.459 |
| PLT×109/L | 127.0±59.5 | 142.6±64.4 | 143.7±70.5 | 0.331 |
| Tumor number | 0.283 | |||
| 1 | 32(62.7%) | 33(76.7%) | 58(69.9%) | |
| 2-3 | 15(29.4%) | 7(16.3%) | 14(16.9%) | |
| >3 | 4(7.8%) | 3(7.0%) | 11(13.3%) | |
| Tumor size, >5cm | 32(62.7%) | 25(58.1%) | 64(77.1%) | 0.056 |
| MVI, positive | 15(29.4%) | 13(30.2%) | 33(39.8%) | 0.378 |
| Differentiation, III–IV | 16(31.4%) | 8(18.6%) | 31(37.3%) | 0.098 |
| Cirrhosis, presence | 73(88.0%) | 34(79.1%) | 48(94.1%) | 0.087 |
| Preoperative AFP, >400 ng/ml | 35(68.6%) | 5(11.6%) | 48(57.8%) | <0.001 |
TBIL=total bilirubin; ALB=albumin; PT=prothrombin time; WBC=white blood cell; PLT=platelet; MVI= micro-vascular invasion; AFP=α-fetoprotein.